ENDRA Life Sciences Inc (NASDAQ:NDRA) saw strong trading volume on Tuesday . 6,376,877 shares traded hands during trading, an increase of 2,382% from the previous session’s volume of 256,877 shares.The stock last traded at $2.64 and had previously closed at $1.90.

ENDRA Life Sciences (NASDAQ:NDRA) last released its earnings results on Monday, March 11th. The company reported ($0.28) earnings per share (EPS) for the quarter.

Several hedge funds have recently added to or reduced their stakes in NDRA. ICM Asset Management Inc. WA raised its holdings in ENDRA Life Sciences by 412.9% in the 4th quarter. ICM Asset Management Inc. WA now owns 671,226 shares of the company’s stock worth $1,007,000 after acquiring an additional 540,356 shares during the last quarter. Geode Capital Management LLC purchased a new position in ENDRA Life Sciences in the 4th quarter worth approximately $71,000. Creative Planning purchased a new position in ENDRA Life Sciences in the 4th quarter worth approximately $53,000. Finally, National Asset Management Inc. purchased a new position in ENDRA Life Sciences in the 4th quarter worth approximately $35,000. Hedge funds and other institutional investors own 18.79% of the company’s stock.

TRADEMARK VIOLATION WARNING: “ENDRA Life Sciences (NDRA) Sees Large Volume Increase” was first posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/endra-life-sciences-ndra-sees-large-volume-increase/2890790.html.

About ENDRA Life Sciences (NASDAQ:NDRA)

ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound systems. It offers diagnostic imaging technologies, such as CT, MRI, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease or internal bleeding.

Recommended Story: Cost of Capital Explained

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.